Update on Corporate Insolvency Resolution Process of FTF Pharma Private Limited, a Wholly Owned Subsidiary of…
As filed · Shilpa Medicare Limited has informed the Exchange about update on Corporate Insolvency Resolution Process of FTF Pharma Private Limited, a Wholly Owned Subsidiary of Shilpa Medicare Limited
What happened
FactUpdate on Corporate Insolvency Resolution Process of FTF Pharma Private Limited, a Wholly Owned Subsidiary of Shilpa Medicare Limited. Corporate Insolvency Resolution Process (CIRP) on FTF Pharma Private Limited, a wholly owned subsidiary. of the Company was directed under Section 9 of the Insolvency and Bankruptcy Code, 2016.
Why it matters
CapitSignal interpretationOnce an insolvency process is admitted, control of the company passes from the board to a resolution professional and equity ranks last in any recovery.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
DelayedWe will try to monetize all these investments.
We should be doing another about INR75 crores to INR100 crores from here on.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Admission or rejection of the application by the tribunal
- Appointment of a resolution professional
- Claims admitted against the company
- So we are expecting to start our clinical study, Phase III clinical study, in Q4 FY '26. (management committed by Q4 FY26)
- We should be doing another about INR75 crores to INR100 crores from here on. (management committed by FY26)
Evidence
- Shilpa Medicare Limited has informed the Exchange about update on Corporate Insolvency Resolution Process of FTF Pharma Private Limited, a Wholly Owned Subsidiary of Shilpa Medicare Limited(opens the original filing in a new tab)
- Earlier statement · Q2 FY26
- Latest statement · Q2 FY26
- Earlier statement · Q2 FY26
How CapitSignal classified this
- Reasoning:
- INSOLVENCY base 93; +2 corroborating keywords; explicit insolvency/default evidence present; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%